Cutaneous toxicity induced by antidepressants and second-generation antipsychotics in the united states food and drug administration adverse event reporting system.
Sign Up to like & getrecommendations! Published in 2024 at "Expert opinion on drug safety"
DOI: 10.1080/14740338.2024.2443962
Abstract: BACKGROUND Adverse cutaneous drug reactions have been reported with most drugs, including antidepressants (ADs) and second-generation antipsychotics (SGAs). The lack of extensive research on the relationship between ADs and SGAs, and cutaneous toxicity remains troubling.… read more here.
Keywords: second generation; drug; toxicity; cutaneous toxicity ... See more keywords
Thromboembolic Events in JAK inhibitors: A Pharmacovigilance Study From 2012 to 2021 Based on FAERS.
Sign Up to like & getrecommendations! Published in 2022 at "British journal of clinical pharmacology"
DOI: 10.1111/bcp.15361
Abstract: INTRODUCTION As a new type of drug developed rapidly in recent years, Janus kinase inhibitors (JAKinibs) have caused controversy due to possible adverse reactions of thromboembolism. The aim of this study was to analyze and… read more here.
Keywords: thrombosis ror025; ror025; study; ror025 ic025 ... See more keywords
Hemophagocytic lymphohistiocytosis and disseminated intravascular coagulation are underestimated, but fatal adverse events in chimeric antigen receptor T-cell therapy.
Sign Up to like & getrecommendations! Published in 2023 at "Haematologica"
DOI: 10.3324/haematol.2022.281455
Abstract: Hematotoxicity is the most common long-term adverse event (AE) after chimeric antigen receptor T-cell (CAR-T) therapy. However, patients who receive CAR-T therapy in pivotal clinical trials are subjected to restrictive selection criteria, always causing an… read more here.
Keywords: cell; aes; therapy; car ... See more keywords